Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

1.2K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.2K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

225
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
225
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

475
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
475
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

762
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
762
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

4.2K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
4.2K
Angina IV: Management01:26

Angina IV: Management

159
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
159

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Persistent behavioral, biological, and physiological sequelae in active-duty treatment-seeking U.S. special operations forces personnel: a cross-sectional study.

Lancet regional health. Americas·2026
Same author

Myths and Facts Regarding Low-Carbohydrate Diets.

Nutrients·2025
Same author

VA physicians intent to leave and correlations to drivers of burnout: a cross-sectional study.

BMC health services research·2025
Same author

Chronic Low Back Pain in a Trapeze Artist-No More "Mousing" Around.

American journal of physical medicine & rehabilitation·2024
Same author

Low-Carbohydrate and Ketogenic Dietary Patterns for Type 2 Diabetes Management.

Federal practitioner : for the health care professionals of the VA, DoD, and PHS·2024
Same author

Low-volume Hydrodissection for the Treatment of Chronic Achilles Tendinopathy.

Military medicine·2022

Related Experiment Video

Updated: Dec 9, 2025

Assessing Whole-Body Lipid-Handling Capacity in Mice
07:57

Assessing Whole-Body Lipid-Handling Capacity in Mice

Published on: November 24, 2020

4.5K

Management of Hypertriglyceridemia: Common Questions and Answers.

Robert C Oh1, Evan T Trivette2, Katie L Westerfield3

  • 1Madigan Army Medical Center, Tacoma, WA, USA.

American Family Physician
|September 15, 2020
PubMed
Summary

High triglyceride levels increase cardiovascular and pancreatitis risks. Lifestyle changes and medications like statins and icosapent can manage hypertriglyceridemia and reduce associated health dangers.

More Related Videos

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

14.9K
Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
11:06

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia

Published on: April 7, 2023

2.6K

Related Experiment Videos

Last Updated: Dec 9, 2025

Assessing Whole-Body Lipid-Handling Capacity in Mice
07:57

Assessing Whole-Body Lipid-Handling Capacity in Mice

Published on: November 24, 2020

4.5K
Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

14.9K
Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
11:06

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia

Published on: April 7, 2023

2.6K

Area of Science:

  • Cardiology
  • Endocrinology
  • Metabolic Disorders

Background:

  • Hypertriglyceridemia, defined as fasting serum triglyceride levels ≥150 mg/dL, is a significant risk factor for cardiovascular disease.
  • Severely elevated levels (≥500 mg/dL) markedly increase the risk of acute pancreatitis.
  • Common contributing factors include obesity, metabolic syndrome, and type 2 diabetes mellitus.

Purpose of the Study:

  • To outline the risks associated with hypertriglyceridemia.
  • To detail management strategies for elevated triglyceride levels.
  • To inform clinical decisions regarding medication use for cardiovascular risk reduction and pancreatitis prevention.

Main Methods:

  • Review of risk factors and diagnostic criteria for hypertriglyceridemia.
  • Analysis of lifestyle modification impacts (diet, exercise) on triglyceride levels.
  • Evaluation of pharmacological interventions including statins, icosapent, fibrates, omega-3 fatty acids, and niacin.
  • Consideration of acute management strategies for pancreatitis secondary to hypertriglyceridemia.

Main Results:

  • Dietary changes (reduced carbohydrates, increased healthy fats and protein) and physical activity can lower triglyceride levels.
  • Statins are indicated for borderline to intermediate cardiovascular risk.
  • High-dose icosapent demonstrates efficacy in reducing cardiovascular mortality in high-risk patients.
  • Fibrates, omega-3s, or niacin may be considered for severely elevated triglycerides to prevent pancreatitis.
  • Insulin infusion and plasmapheresis are options for persistent high triglycerides during acute pancreatitis.

Conclusions:

  • Effective management of hypertriglyceridemia involves a multi-faceted approach combining lifestyle changes and targeted pharmacotherapy.
  • Risk stratification is crucial for guiding treatment decisions to mitigate cardiovascular events and pancreatitis.
  • Further research is needed to confirm the efficacy of certain agents in preventing pancreatitis in clinical trials.